Illumina (company)
_logo.jpg){kind=logo} |
|
| Public | |
| Traded as |
NASDAQ: ILMN NASDAQ-100 Component S&P 500 Component |
| Industry | Biotechnology |
| Founded | 1998 |
| Founder |
|
| Headquarters | San Diego, California, U.S. |
|
Key people
|
Francis deSouza (President & CEO) |
| Revenue | $2.2 billion (2015) |
| Website | www |
Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. In 2014, Illumina was named the world's smartest company by MIT Technology Review. Using its technologies, the company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. This technology had purportedly by 2013 reduced the cost of sequencing a human genome to US$4,000, down from a price of US$1 million in 2007. Customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. Its tools provide researchers with the capability to perform genetic tests needed to extract medical information from advances in genomics and proteomics. Its headquarters are located in San Diego, California.
Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee. While working with CW Group, a venture capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. Illumina completed its initial public offering in July 2000.
Illumina began offering single nucleotide polymorphism (SNP) genotyping services in 2001 and launched its first system, the Illumina BeadLab, in 2002, using GoldenGate Genotyping technology. Illumina currently offers microarray-based products and services for an expanding range of genetic analysis sequencing, including SNP genotyping, gene expression, and protein analysis. Illumina's technologies are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
...
Wikipedia